Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 22 Jun 2023 07:00 CEST |
BERGENBIO | BerGenBio Reports First Quarter 2023 Financial Results and Provides Business Update | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 19 Jun 2023 16:40 CEST |
BERGENBIO | BerGenBio ASA - Updated timeline for delivery of Offer Shares and Warrants in connection with the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Jun 2023 08:10 CEST |
BERGENBIO | BerGenBio ASA - Mandatory notification of trade, allocations to primary insiders and close associates in the Rights Issue | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 14 Jun 2023 17:21 CEST |
BERGENBIO | BergenBio ASA - Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 14 Jun 2023 16:48 CEST |
BERGENBIO | BerGenBio - Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 14 Jun 2023 15:20 CEST |
BERGENBIO | BerGenBio ASA - Correction of final results of the Rights Issue | 20103010 Biotechnology | Inside information |
| 14 Jun 2023 13:30 CEST |
BERGENBIO | BerGenBio ASA - Final results of the Rights Issue | 20103010 Biotechnology | Inside information |
| 13 Jun 2023 20:30 CEST |
BERGENBIO | BerGenBio ASA - Preliminary results indicates an oversubscribed Rights Issue of gross NOK 250 million | 20103010 Biotechnology | Inside information |
| 13 Jun 2023 09:49 CEST |
BERGENBIO | Mandatory notification of trade by Primary Insiders and close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 13 Jun 2023 07:00 CEST |
BERGENBIO | BerGenBio ASA - Last day of the Subscription Period in the Rights Issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Jun 2023 22:01 CEST |
BERGENBIO | Mandatory notification of trade by Primary Insiders and close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 07 Jun 2023 17:20 CEST |
BERGENBIO | Mandatory notification of trade by Primary Insiders and close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 07 Jun 2023 07:00 CEST |
BERGENBIO | BerGenBio ASA - Last day of trading in Subscription Rights | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Jun 2023 16:47 CEST |
BERGENBIO | BerGenBio - Disclosure of large shareholding | 20103010 Biotechnology | Major shareholding notifications |
| 05 Jun 2023 22:11 CEST |
BERGENBIO | BerGenBio Announces Data from Bemcentinib Trial in Mesothelioma Presented at ASCO | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 May 2023 18:19 CEST |
BERGENBIO | BerGenBio to Participate in Investor Webcast and Q&A | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 May 2023 13:28 CEST |
BERGENBIO | BerGenBio ASA: Receipt of subscription rights in the rights issue by primary insiders and their close associates | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 30 May 2023 07:00 CEST |
BERGENBIO | BerGenBio ASA - Commencement of the subscription period for the rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 26 May 2023 14:41 CEST |
BERGENBIO | BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue | 20103010 Biotechnology | Prospectus / admission document |
| 25 May 2023 08:04 CEST |
BERGENBIO | Shareholder disclosure | 20103010 Biotechnology | Major shareholding notifications |
| 25 May 2023 07:00 CEST |
BERGENBIO | BerGenBio Announces Abstracts Accepted for Presentation at 2023 ASCO | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 May 2023 20:12 CEST |
BERGENBIO | Mandatory notification of trade by related party to Primary Insiders | 20103010 Biotechnology | Mandatory notification of trade primary insiders |
| 23 May 2023 07:00 CEST |
BERGENBIO | BGBIO - Ex. subscription rights today | 20103010 Biotechnology | Ex Date |
| 22 May 2023 18:01 CEST |
BERGENBIO | BerGenBio ASA: Annual general meeting held | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 May 2023 12:05 CEST |
BERGENBIO | BerGenBio ASA - Updated key information relating to the preferential rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 20 May 2023 12:00 CEST |
BERGENBIO | BERGENBIO ASA - Terms of the partially underwritten rights issue | 20103010 Biotechnology | Inside information |
| 09 May 2023 18:14 CEST |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 May 2023 18:14 CEST |
BERGENBIO | BerGenBio to hold business update conference call | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2023 15:00 CEST |
BERGENBIO | BERGENBIO ASA: Notice of Annual General Meeting | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Apr 2023 13:01 CEST |
BERGENBIO | BERGENBIO ASA: Board approval of 2022 Annual Financial Statement and Annual Report 2022 | 20103010 Biotechnology | Annual financial and audit Reports |
| 25 Apr 2023 17:56 CEST |
BERGENBIO | BerGenBio ASA - Key information relating to the preferential rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Apr 2023 17:49 CEST |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Apr 2023 17:48 CEST |
BERGENBIO | BerGenBio ASA: Proposed partially underwritten rights issue | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Apr 2023 17:48 CEST |
BERGENBIO | BerGenBio ASA: Foreslår delvis garantert fortrinnsrettsemisjon | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 18 Apr 2023 07:00 CEST |
BERGENBIO | BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 29 Mar 2023 20:39 CEST |
BERGENBIO | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 28 Mar 2023 08:00 CEST |
BERGENBIO | BerGenBio to Present at Upcoming Scientific Conferences | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Mar 2023 07:00 CET |
BERGENBIO | BerGenBio to Present at the Carnegie Nordic Healthcare Conference | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 09 Mar 2023 11:00 CET |
BERGENBIO | BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |